Nav: Home

'Google Maps' for cancer: Image-based computer model reveals finer details of tumor blood flow

May 06, 2019

Johns Hopkins Medicine researchers say they have developed something akin to a "Google Maps" approach for more accurately computing and visualizing the structural and functional blood vessel changes needed for tumor growth. By pairing high-quality 3D imaging data of tumor specimens from animal models with sophisticated mathematical formulas, the researchers say they now have a model that accurately represents blood traffic inside tumors, including the complex blood flow, oxygenation and structural changes that occur.

This work was published March 27 in Nature Scientific Reports.

Arvind Pathak, Ph.D., the study's leader, says the project was developed out of the need to address the complexities of cancer biology in growing and developing tumors. He saw the need for better predictive models, as many existing models employed rudimentary approximations of the complex geometry of a tumor's blood vessels.

"Poor representations of the tumor 'microenvironment' make models and the research based on them less accurate. So I thought, how I can use my imaging expertise to improve the information available to modelers?" says Pathak, associate professor of radiology and biomedical engineering at the Johns Hopkins University School of Medicine and a member of the Johns Hopkins Kimmel Cancer Center.

To create a model that more precisely reflected the structure and behavior of tumors, his research team implanted mice with human breast tumor cells and imaged the resulting tumors using 3D magnetic resonance microscopy and micro-CT imaging. These high-resolution 3D images provided detailed information about a tumor's volume and the structure of its blood vessel networks.

With the underlying blood vessel structure mapped, Pathak and his research team scoured the scientific literature to find information on how these structures would likely behave in a living system. Specifically, they searched for studies that included measurements of blood pressure, blood flow and volume in vessels similar to those seen in their tumors.

Using this information, the group collaborated with Aleksander Popel's Systems Biology Laboratory in the Department of Biomedical Engineering at the Johns Hopkins University School of Medicine to develop a set of mathematical formulas designed to represent these aspects of tumors. They did this by combining data from previously published studies with the information they collected.

"The image-based model comprises thousands of data points about the predicted blood flow and intravascular oxygenation throughout tumors," Pathak says.

The next challenge for the group was to make the information they collected easy to see and understand, in much the way that web-based geographical maps can be easily seen and overlaid with different kinds of useful information such as travel time, traffic activity, detours and average speed.

"We had to create a completely new way to represent the information we had generated so that it is meaningful and not overwhelming to those who need to understand and use it," says Pathak.

To do that, Pathak recruited Akanksha Bhargava, Ph.D., a mechanical engineer and postdoctoral fellow in the Systems Biology Laboratory, to build on the mathematical models established by Spyros Stamatelos, Ph.D. "We brainstormed about different ways to superimpose the modeling results onto the underlying blood vessel geometry without compromising the complexity and richness of the data," says Bhargava.

The result, he says, was a 3D representation of the blood vessel network of each tumor with a color-coded map of the traffic-like movements of blood through the vessels that feed it. "It looked an awful lot like Google Maps," says Pathak, "The blood vessel segments are the streets and the blood flow in each segment is analogous to the traffic along each street." And like mapping apps, he says, the model gives researchers a more accurate depiction of what is happening within a tumor at any given time, adds Pathak. These compelling visualizations have already garnered the attention of the scientific community and were featured as the "biomedical picture of the day" by the MRC London Institute of Medical Sciences.

Pathak says the team plans to make these images freely available to the scientific community for research purposes. The model can be made interactive, so that users can alter parameters such as the width of blood vessels to observe the effect on blood flow and the delivery of drugs or other treatments on the tumor.

The investigators caution that the approach is not directly applicable to human tumors yet. But, says Pathak, "As our ability to obtain high-resolution images in the clinic improves, we hope that this tool can be adapted to provide a noninvasive way to predict the behavior of an individual patient's cancer and customize their therapy."

At present, the model should be useful for bioengineers and cancer biologists to more easily study aspects of tumor biology "in silico," as well as conduct tests for potential therapies.
-end-
Other researchers involved in this study include Eugene Kim of the Johns Hopkins University School of Medicine.

This work was supported by the National Cancer Institute (1R01CA196701, 1R21CA175784, 5R01CA138264).

The authors declare no competing interests.

Johns Hopkins Medicine

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...